CervoMed Inc [CRVO] stock is trading at $8.51, down -3.08%. An important factor to consider is whether the stock is rising or falling in short-term value. The CRVO shares have gain 2.28% over the last week, with a monthly amount drifted -3.30%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CervoMed Inc [NASDAQ: CRVO] stock has seen the most recent analyst activity on March 13, 2025, when Chardan Capital Markets upgraded its rating to a Buy but kept the price target unchanged to $14 for it. Previously, H.C. Wainwright downgraded its rating to Neutral on December 17, 2024. On December 11, 2024, downgrade downgraded it’s rating to Underweight. Chardan Capital Markets downgraded its rating to a Neutral. D. Boral Capital downgraded its rating to a Hold. ROTH MKM started tracking with a Buy rating for this stock on December 06, 2024, and assigned it a price target of $45. In a note dated December 05, 2024, H.C. Wainwright initiated an Buy rating and provided a target price of $42 on this stock.
CervoMed Inc [CRVO] stock has fluctuated between $1.80 and $22.57 over the past year. Currently, Wall Street analysts expect the stock to reach $17.31 within the next 12 months. CervoMed Inc [NASDAQ: CRVO] shares were valued at $8.51 at the most recent close of the market. An investor can expect a potential return of 103.41% based on the average CRVO price forecast.
Analyzing the CRVO fundamentals
CervoMed Inc [NASDAQ:CRVO] reported sales of 9.31M for the trailing twelve months, which represents a drop of -18.31%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -6.37%, Pretax Profit Margin comes in at -5.68%, and Net Profit Margin reading is -5.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.44 and Total Capital is -0.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, CervoMed Inc’s Current Ratio is 9.78. On the other hand, the Quick Ratio is 9.78, and the Cash Ratio is 5.64. Considering the valuation of this stock, the price to sales ratio is 7.95, the price to book ratio is 2.14.
Transactions by insiders
Recent insider trading involved ELDER WILLIAM ROBERT, CFO, GC & Secretary, that happened on May 14 ’25 when 4233.0 shares were purchased. CFO & GC, ELDER WILLIAM ROBERT completed a deal on Aug 27 ’24 to buy 1000.0 shares.
